Molecular markers of response and toxicity to FOLFOX chemotherapy in metastatic colorectal cancer

被引：0
|
作者：
W Chua
D Goldstein
C K Lee
H Dhillon
M Michael
P Mitchell
S J Clarke
B Iacopetta
机构：
[1] Sydney Cancer Centre,Department of Medical Oncology
[2] Concord Repatriation General Hospital,Department of Medical Oncology
[3] Prince of Wales Hospital,Division of Haematology and Medical Oncology
[4] NHMRC Clinical Trials Centre,Department of Medical Oncology
[5] Centre of Medical Psychology and Evidence-based Decision-Making,undefined
[6] University of Sydney,undefined
[7] Peter MacCallum Cancer Centre,undefined
[8] Austin Hospital,undefined
[9] School of Surgery,undefined
[10] University of Western Australia,undefined
来源：
British Journal of Cancer | 2009年 / 101卷
关键词：
colorectal cancer; metastatic; chemotherapy; predictive factors;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：998 / 1004
页数：6
相关论文
共 50 条
  • [1] Molecular markers of response and toxicity to FOLFOX chemotherapy in metastatic colorectal cancer
    Chua, W.
    Goldstein, D.
    Lee, C. K.
    Dhillon, H.
    Michael, M.
    Mitchell, P.
    Clarke, S. J.
    Iacopetta, B.
    BRITISH JOURNAL OF CANCER, 2009, 101 (06) : 998 - 1004
  • [2] Molecular Markers Predictive of Chemotherapy Response in Colorectal Cancer
    Shiovitz S.
    Grady W.M.
    Current Gastroenterology Reports, 2015, 17 (2)
  • [3] Popliteal pseudoaneurysm after FOLFOX chemotherapy for metastatic colorectal cancer
    Cosic, Luka
    Theivendren, Mayo
    Spanger, Manfred
    Weinberg, Laurence
    INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 2019, 63 : 1 - 4
  • [4] Predicting drug response and toxicity in metastatic colorectal cancer: the role of germline markers
    Bignucolo, Alessia
    Scarabel, Lucia
    Toffoli, Giuseppe
    Cecchin, Erika
    De Mattia, Elena
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2022, 15 (06) : 689 - 713
  • [5] Molecular Predictors of Response to Chemotherapy in Colorectal Cancer
    Dienstmann, Rodrigo
    Vilar, Eduardo
    Tabernero, Josep
    CANCER JOURNAL, 2011, 17 (02) : 114 - 126
  • [6] Molecular Markers in the Treatment of Metastatic Colorectal Cancer
    Wilson, Peter M.
    LaBonte, Melissa J.
    Lenz, Heinz-Josef
    CANCER JOURNAL, 2010, 16 (03) : 262 - 272
  • [7] Oxaliplatin,Fluorouracil and Leucovorin (FOLFOX) as First-line Chemotherapy for Metastatic or Recurrent Colorectal Cancer Patients
    Bing Han Ruihua Xu Yanxia Shi Huiyan Luo Xiaojuan Xiang Yuhong Li Li Zhang Tongyu Lin Youjian HeDepartment of Medical Oncology
    Chinese Journal of Clinical Oncology, 2007, (06) : 397 - 400
  • [8] Neutropaenia as a prognostic factor in metastatic colorectal cancer patients undergoing chemotherapy with first-line FOLFOX
    Shitara, Kohei
    Matsuo, Keitaro
    Takahari, Daisuke
    Yokota, Tomoya
    Inaba, Yoshitaka
    Yamaura, Hidekazu
    Sato, Yozo
    Najima, Mina
    Ura, Takashi
    Muro, Kei
    EUROPEAN JOURNAL OF CANCER, 2009, 45 (10) : 1757 - 1763
  • [9] Metastatic urachal cancer responding to FOLFOX chemotherapy
    Tran, Ben
    McKendrick, Joe
    CANADIAN JOURNAL OF UROLOGY, 2010, 17 (02) : 5120 - 5123
  • [10] Gene expression profile predictive of response to chemotherapy in metastatic colorectal cancer
    Estevez-Garcia, Purificacion
    Rivera, Fernando
    Molina-Pinelo, Sonia
    Benavent, Marta
    Gomez, Javier
    Luisa Limon, Maria
    Dolores Pastor, Maria
    Martinez-Perez, Julia
    Paz-Ares, Luis
    Carnero, Amancio
    Garcia-Carbonero, Rocio
    ONCOTARGET, 2015, 6 (08) : 6151 - 6159
12345